Crinetics Pharmaceuticals (CRNX) Inventory (2025 - 2026)

Crinetics Pharmaceuticals (CRNX) recorded quarterly Inventory of $3.1 million in Q1 2026, up 51.53% quarter-over-quarter from $2.0 million in Q4 2025.

Crinetics Pharmaceuticals (CRNX) Inventory (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Inventory history runs 2 years deep, the most recent figure standing at $3.1 million for Q1 2026.

  • In Q1 2026, Inventory changed N/A year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
  • Inventory was $3.1 million for Q1 2026 at Crinetics Pharmaceuticals, up from $2.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $3.1 million in Q1 2026 to a low of $2.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 32.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.77 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Crinetics Pharmaceuticals 3.75 Bn 3.75 Bn 10.53 Mn 3.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.06 Mn
Dec 31, 2025 2.02 Mn